LexaGene’s MiQLab has direct benefits for veterinary clinics. Using LexaGene’s proven point-of-care diagnostics for evidence-based treatment of common bacterial infections found in companion animals may also result in cost savings.
When thinking about how best to isolate a bacterium, scientists were often held to the standards of taking time to grow cultures in laboratories, a process involving days or weeks to simply prepare the sample for testing. In today’s everchanging world, LexaGene’s MiQLab™ now allows for samples to be captured at point-of-care, inserted into a cartridge, mixed with a reagent, and run through a testing system, shortening the time to result to hours instead of days.
More than ever, vet practices are looking for efficient and cost-effective methodologies to take control of these variables and manage costs.
The global bioburden testing market for bio-pharma contamination is approximately $10B, with over 350M tests run annually. LexaGene provides early detection for mycoplasma, aiding in validating product quality for biopharmaceutical manufacturers.
The MiQLab Bacterial & AMR test empowers veterinarians to make quick evidenced-based treatment decisions in-clinic.
LexaGene developed assays for pathogen detection and whether they possess drug resistant genes.
Single-use manufacturing has provided for a large degree of flexibility in terms of production volumes but have also brought about efficiencies in sterility control by reducing hands on cleaning and sterilization necessary for stainless steel.
Contamination control of bioprocessing cell lines is essential. The same environments that encourage desirable microbiological growth also encourage growth of undesirable contaminants including yeasts, molds, mycoplasma, bacteria, and viruses.
Improvements in qPCR testing are bringing point-of-care molecular diagnostics into practical use.
Making qPCR molecular diagnostics accessible at point-of-care changed how we detect and treat major infectious diseases.
Careful evaluation of a patient’s medical history, their clinical symptoms, and consultation of available diagnostic test results are essential components of implementing an effective antimicrobial stewardship program at a veterinary clinic.
On-site qPCR testing lets veterinarians make better treatment decisions faster than waiting on culture and sensitivity testing from a reference laboratory.